Akili
PureTech Health’s Founded Entity Akili announces positive data from adult ADHD trial
May 4, 2023Medical Communications ADHD, Akili, Neurology, PureTech Health, clinical trials
Clinical-stage biotherapeutics company PureTech Health has reported that its Founded Entity Akili, a digital medicine company, has announced positive topline …
Akili’s video game digital treatment shows promise in ADHD, eyes FDA approval
December 4, 2017Research and Development, Sales and Marketing ADHD, AKL-T01, Akili, FDA, pharma, video game
Akili, an unlisted affiliate of London-listed PureTech Health, has unveiled top-line results of AKL-T01, a novel digital medicine which takes …
Digital software shows benefit in ADHD trial
October 30, 2015Medical Communications ADHD, Akili, PureTech Health, attention deficit hyperactivity disorder, digital tech
A pilot study of a digital health technology designed to improve symptoms of attention deficit hyperactivity disorder (ADHD) in children …
Latest content
Long-acting therapies set to reshape HIV treatment market
August 21, 2026
MHRA approves Romvimza for tenosynovial giant cell tumour
August 20, 2026
